Clinical Trial Update: Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients [Phase 3]

View source ↗

Summary

An extension study of P1101 is planned after completion of Phase 2 in polycythemia vera or Phase 3 in essential thrombocythemia; the trial is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Polycythemia Vera

Drugs mentioned

• P1101

Snippet

Sponsor: PharmaEssentia Japan K.K. | Conditions: Polycythemia Vera (PV) | Phase 3 | Status: RECRUITING